This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Field, A K
Right arrow Articles by Biron, K K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Field, A K
Right arrow Articles by Biron, K K

Next Article 

Clin Microbiol Rev. 1994 January; 7(1): 1-13

"The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.

A K Field and K K Biron

Hybridon, Inc., Worcester, Massachusetts 01605.

SUMMARY

In the past 4 years, interest in drug-resistant herpesviruses has evolved from the realm of academic laboratory studies to that of great clinical importance. Recurrent and persistent infections due to the herpes simplex viruses, varicella-zoster virus, and human cytomegalovirus have been an unwelcome consequence of immunosuppression in graft recipients, cancer patients, and those suffering from AIDS. Treatment of these infections with the available antiviral drugs, such as acyclovir, ganciclovir, and foscarnet, has resulted in both clinical benefit and the emergence of drug-resistant variants. In addition, the role of Epstein-Barr virus is being clarified for an array of disease syndromes, and therapeutic approaches are beginning to emerge. In the present review, the emergence and clinical importance of drug resistance among the herpesviruses have been explored. Furthermore, particular attention has been focused on our understanding of the mechanisms of drug resistance and how that understanding will guide us in the development of more effective antiviral drugs and drug usage.

Clin Microbiol Rev. 1994 January; 7(1): 1-13




This article has been cited by other articles:

  • Schroer, J., Shenk, T. (2008). Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 105: 19468-19473 [Abstract] [Full Text]  
  • Wang, G.-Q., Suzutani, T., Yamamoto, Y., Fukui, Y., Nozawa, N., Schmid, D. S., Kurane, I., Inoue, N. (2006). Generation of a Reporter Cell Line for Detection of Infectious Varicella-Zoster Virus and Its Application to Antiviral Studies. Antimicrob. Agents Chemother. 50: 3142-3145 [Abstract] [Full Text]  
  • Evers, D. L., Komazin, G., Ptak, R. G., Shin, D., Emmer, B. T., Townsend, L. B., Drach, J. C. (2004). Inhibition of Human Cytomegalovirus Replication by Benzimidazole Nucleosides Involves Three Distinct Mechanisms. Antimicrob. Agents Chemother. 48: 3918-3927 [Abstract] [Full Text]  
  • Komazin, G., Ptak, R. G., Emmer, B. T., Townsend, L. B., Drach, J. C. (2003). Resistance of Human Cytomegalovirus to the Benzimidazole L-Ribonucleoside Maribavir Maps to UL27. J. Virol. 77: 11499-11506 [Abstract] [Full Text]  
  • De Clercq, E. (2003). Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections. Clin. Microbiol. Rev. 16: 569-596 [Abstract] [Full Text]  
  • Thomsen, D. R., Oien, N. L., Hopkins, T. A., Knechtel, M. L., Brideau, R. J., Wathen, M. W., Homa, F. L. (2003). Amino Acid Changes within Conserved Region III of the Herpes Simplex Virus and Human Cytomegalovirus DNA Polymerases Confer Resistance to 4-Oxo-Dihydroquinolines, a Novel Class of Herpesvirus Antiviral Agents. J. Virol. 77: 1868-1876 [Abstract] [Full Text]  
  • Chutkowski, C., Olson, B., McDonough, A., Mahoney, J., McSharry, J. J. (2002). Use of a Single Monoclonal Antibody To Determine the Susceptibilities of Herpes Simplex Virus Type 1 and Type 2 Clinical Isolates to Acyclovir. CVI 9: 1379-1381 [Abstract] [Full Text]  
  • Evers, D. L., Breitenbach, J. M., Borysko, K. Z., Townsend, L. B., Drach, J. C. (2002). Inhibition of Cyclin-Dependent Kinase 1 by Purines and Pyrrolo[2,3-d]Pyrimidines Does Not Correlate with Antiviral Activity. Antimicrob. Agents Chemother. 46: 2470-2476 [Abstract] [Full Text]  
  • Buerger, I., Reefschlaeger, J., Bender, W., Eckenberg, P., Popp, A., Weber, O., Graeper, S., Klenk, H.-D., Ruebsamen-Waigmann, H., Hallenberger, S. (2001). A Novel Nonnucleoside Inhibitor Specifically Targets Cytomegalovirus DNA Maturation via the UL89 and UL56 Gene Products. J. Virol. 75: 9077-9086 [Abstract] [Full Text]  
  • Johnson, R. A., Huong, S.-M., Huang, E.-S. (2000). Activation of the Mitogen-Activated Protein Kinase p38 by Human Cytomegalovirus Infection through Two Distinct Pathways: a Novel Mechanism for Activation of p38. J. Virol. 74: 1158-1167 [Abstract] [Full Text]  
  • Cotarelo, M., Catalan, P., Sanchez-Carrillo, C., Menasalvas, A., Cercenado, E., Tenorio, A., Bouza, E. (1999). Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents. J Antimicrob Chemother 44: 705-708 [Abstract] [Full Text]  
  • Lee, N. Y., Tang, Y.-W., Espy, M. J., Kolbert, C. P., Rys, P. N., Mitchell, P. S., Day, S. P., Henry, S. L., Persing, D. H., Smith, T. F. (1999). Role of Genotypic Analysis of the Thymidine Kinase Gene of Herpes Simplex Virus for Determination of Neurovirulence and Resistance to Acyclovir. J. Clin. Microbiol. 37: 3171-3174 [Abstract] [Full Text]  
  • Gustafson, E. A., Chillemi, A. C., Sage, D. R., Fingeroth, J. D. (1998). The Epstein-Barr Virus Thymidine Kinase Does Not Phosphorylate Ganciclovir or Acyclovir and Demonstrates a Narrow Substrate Specificity Compared to the Herpes Simplex Virus Type 1 Thymidine Kinase. Antimicrob. Agents Chemother. 42: 2923-2931 [Abstract] [Full Text]  
  • Tang, Y.-W., Rys, P. N., Rutledge, B. J., Mitchell, P. S., Smith, T. F., Persing, D. H. (1998). Comparative Evaluation of Colorimetric Microtiter Plate Systems for Detection of Herpes Simplex Virus in Cerebrospinal Fluid. J. Clin. Microbiol. 36: 2714-2717 [Abstract] [Full Text]  
  • Cihlar, T., Fuller, M. D., Cherrington, J. M. (1998). Characterization of Drug Resistance-Associated Mutations in the Human Cytomegalovirus DNA Polymerase Gene by Using Recombinant Mutant Viruses Generated from Overlapping DNA Fragments. J. Virol. 72: 5927-5936 [Abstract] [Full Text]  
  • Krosky, P. M., Underwood, M. R., Turk, S. R., Feng, K. W.-H., Jain, R. K., Ptak, R. G., Westerman, A. C., Biron, K. K., Townsend, L. B., Drach, J. C. (1998). Resistance of Human Cytomegalovirus to Benzimidazole Ribonucleosides Maps to Two Open Reading Frames: UL89 and UL56. J. Virol. 72: 4721-4728 [Abstract] [Full Text]  
  • Underwood, M. R., Harvey, R. J., Stanat, S. C., Hemphill, M. L., Miller, T., Drach, J. C., Townsend, L. B., Biron, K. K. (1998). Inhibition of Human Cytomegalovirus DNA Maturation by a Benzimidazole Ribonucleoside Is Mediated through the UL89 Gene Product. J. Virol. 72: 717-725 [Abstract] [Full Text]  
  • Tang, Y.-W., Procop, G. W., Persing, D. H. (1997). Molecular diagnostics of infectious diseases. Clin. Chem. 43: 2021-2038 [Abstract] [Full Text]  
  • Kakinuma, H., Itoh, E. (1997). A Continuous Infusion of Acyclovir for Severe Hemorrhagic Varicella. NEJM 336: 732-733 [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»